96748-86-6

Usage

Uses

Used in Anticancer Applications:
Deoxynyboquinone is used as an anticancer agent for its ability to selectively target and induce death in cancer cells. Its mechanism of action involves the disruption of cellular processes essential for cancer cell survival and proliferation, making it a valuable tool in the fight against various types of cancer.
Used in Drug Development:
Deoxynyboquinone and its derivatives are used in the development of selective anticancer therapies, offering a targeted approach to cancer treatment. deoxynyboquinone's unique properties allow for the design of drugs that can specifically target cancer cells, minimizing damage to healthy cells and reducing side effects associated with traditional chemotherapy.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, deoxynyboquinone is utilized as a key component in the formulation of novel anticancer drugs. Its potential to induce cancer cell death and its selectivity for cancer cells make it an attractive candidate for the development of more effective and less toxic cancer treatments.
Used in Cancer Research:
Deoxynyboquinone is also used in cancer research as a tool to study the mechanisms underlying cancer cell death and to identify potential targets for therapeutic intervention. Its unique properties provide valuable insights into the biology of cancer and contribute to the advancement of cancer treatment strategies.

Upstream product

• 30408-37-8 diazaanthracenol 
• 1221589-79-2 2,2'-(4,6-dichloro-5-methoxy-1,3-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 
• 1221589-80-5 2,4-dichloro-1,5-diiodo-3-methoxybenzene 
• 1984-65-2 2,6-dichloroanisole 
• 50553-58-7 10-methoxy-1,4,6-trimethyl-1H,9H-pyrido[3,2-g]quinoline-2,8-dione 
• 1221589-84-9 C₂₄H₂₄N₂O₄ 
• 1430798-63-2 C₂₄H₂₆Cl₂N₂O₄ 
• 1221589-81-6 (4,6-dichloro-5-methoxy-1,3-phenylene)bis(trimethylsilane) 

Relevant academic research and scientific papers

COMPOUNDS AND ANTI-TUMOR NQO1 SUBSTRATES

Compounds of Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compounds are useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.

Chemistry and biology of deoxynyboquinone, a potent inducer of cancer cell death

Deoxynyboquinone (DNQ) is a potent antineoplastic agent with an unknown mechanism of action. Here we describe a facile synthetic route to this anthraquinone, and we use this material to determine the mechanism by which DNQ induces death in cancer cells. DNQ was synthesized in seven linear steps through a route employing three palladium-mediated coupling reactions. Experiments performed on cancer cells grown in hypoxia and normoxia strongly suggest that DNQ undergoes bioreduction to its semiquinone, which then is re-oxidized by molecular oxygen, forming superoxide that induces cell death. Furthermore, global transcript profiling of cells treated with DNQ shows elevation of transcripts related to oxidative stress, a result confirmed at the protein level by Western blotting. In contrast to most other antineoplastic agents that generate reactive oxygen species (ROS), DNQ potently induces death of cancer cells in culture, with IC50 values between 16 and 210 nM. In addition, unlike the experimental therapeutic elesclomol, DNQ is still able to induce cancer cell death under hypoxic conditions. This mechanistic understanding of DNQ will allow for a more comprehensive evaluation of the potential of direct ROS generation as an anticancer strategy, and DNQ itself has potential as a novel anticancer agent.